{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:07:58Z","timestamp":1787764078063,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10430372310017"],"award-info":[{"award-number":["10430372310017"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10430372310017"],"award-info":[{"award-number":["10430372310017"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study investigated the implementation of ultra-hypofractionated radiotherapy (i.e. 5 fractions) in DCIS and early-stage breast cancer, factors associated with its use, and variation across radiotherapy institutes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Registry and questionnaire data were used. Registry data included data from the Netherlands Cancer Registry and the NABON Breast Cancer Audit-Radiotherapy (NBCA-R). Women eligible for 5 fractions were included. Trends and variation were visualised using trendlines and case-mix adjusted boxplots. Logistic regression was applied to investigate which factors were associated with the use of 5 fractions. In April 2024 a questionnaire was distributed among radiotherapy institutes to identify facilitators and barriers for implementation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The current study included 16,115 women. In 2020, 18.5% of the eligible women received 5 fractions, compared to 60.8% in 2023. The lowest variation between radiotherapy institutes was found in 2023 (median: 60.4%, interquartile range: 53.3\u201370.6%). Age, tumour grade, multifocality, (y)pT, (y)pN, radiotherapy target volume, type of radiotherapy institute, and start year of radiation were associated with the chance of receiving 5 fractions. Sixteen out of the 19 radiotherapy institutes completed the questionnaire, showing variation in age and radiotherapy target volume for which the schedule was used. Most institutes mentioned no barriers for using 5 fractions. Questionnaire data confirmed the trendline finding that national consensus meetings were essential for largescale implementation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The use of ultra-hypofractionated radiotherapy has increased during the past four years, with reduced variation across Dutch institutes. Registry and questionnaire data indicated that national consensus meetings were instrumental in driving implementation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13014-025-02669-w","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T13:34:38Z","timestamp":1749735278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020\u20132023, using registry data and questionnaires"],"prefix":"10.1186","volume":"20","author":[{"given":"Anouk H.","family":"Eijkelboom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva J. A.","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel R.","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulien","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa C.","family":"van Maaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margriet G. A.","family":"Sattler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enja J.","family":"Bantema-Joppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e H. J. G.","family":"van den Bongard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the NABON-COVID-19 Consortium and the COVID and Cancer-NL Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J. T.","family":"Luiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"van Leeuwen-Stok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Guerrero","family":"Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E. M. M.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. B.","family":"Koppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Hooning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. J.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Smidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Linn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T. F. D. Vrancken","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. P.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M.","family":"Verkooijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. H. J. G.","family":"van den Bongard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bessems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H.","family":"Honkoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Westenend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"van der Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. W.","family":"Menke-van der Houven van Oordt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Manten-Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. T.","family":"van Ravesteyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Korevaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Verloop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J. M.","family":"Siemerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. W. G.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A. M.","family":"Mureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"2669_CR1","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1200\/JCO.19.02750","volume":"38","author":"AM Brunt","year":"2020","unstructured":"Brunt AM, Haviland JS, Sydenham M, Agrawal RK, Algurafi H, Alhasso A, Barrett-Lee P, Bliss P, Bloomfield D, Bowen J. Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer. J Clin Oncol. 2020;38:3261\u201372. https:\/\/doi.org\/10.1200\/JCO.19.02750.","journal-title":"J Clin Oncol."},{"issue":"10237","key":"2669_CR2","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"AM Brunt","year":"2020","unstructured":"Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, Chan C, Churn M, Cleator S, Coles CE, Goodman A, Harnett A, Hopwood P, Kirby AM, Kirwan CC, Morris C, Nabi Z, Sawyer E, Somaiah N, Stones L, Syndikus I, Bliss JM, Yarnold JR, Alhasso A, Armstrong A, Bliss J, Bloomfield D, Bowen J, Brunt M, Chan C, Chantler H, Churn M, Cleator S, Coles C, Donovan E, Goodman A, Griffin S, Haviland J, Hopwood P, Kirby A, Kirk J, Kirwan C, MacLennan M, Morris C, Nabi Z, Sawyer E, Sculphur M, Sinclair J, Somaiah N, Stones L, Sydenham M, Syndikus I, Tremlett J, Venables K, Wheatley D, Yarnold J. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395(10237):1613\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(20)30932-6.","journal-title":"Lancet"},{"key":"2669_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.clon.2020.03.006","volume":"32","author":"C Coles","year":"2020","unstructured":"Coles C, Aristei C, Bliss J, Boersma L, Brunt A, Chatterjee S, Hanna G, Jagsi R, Person OK, Kirby A, Mjaaland I, Meattini I, Luis AM, Marta GN, Offersen B, Poortmans P, Rivera S. International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic. Clin Oncol. 2020;32:279\u201381. https:\/\/doi.org\/10.1016\/j.clon.2020.03.006.","journal-title":"Clin Oncol"},{"key":"2669_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100877","volume":"7","author":"KL Corrigan","year":"2022","unstructured":"Corrigan KL, Lei X, Ahmad N, Arzu I, Bloom E, Chun SG, Goodman C, Hoffman KE, Joyner M, Mayo L. Adoption of ultrahypofractionated radiation therapy in patients with breast cancer. Adv Radiat Oncol. 2022;7: 100877. https:\/\/doi.org\/10.1016\/j.adro.2021.100877.","journal-title":"Adv Radiat Oncol"},{"issue":"9935","key":"2669_CR5","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), McGale P, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Darby S. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(14)60488-8.","journal-title":"Lancet"},{"key":"2669_CR6","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwi J, Gray R, Pierce L, Whelan T, Wang Y, Peto R. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378:1707\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(11)61629-2.","journal-title":"Lancet"},{"key":"2669_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2024.100807","volume":"47","author":"AH Eijkelboom","year":"2024","unstructured":"Eijkelboom AH, Stam MR, van den Bongard DH, Sattler MG, Bantema-Joppe EJ, Siesling S, van Maaren MC. Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands. Clin Transl Radiat Oncol. 2024;47: 100807. https:\/\/doi.org\/10.1016\/j.ctro.2024.100807.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"11","key":"2669_CR8","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"START Trialists\u2019 Group, Haviland JS, Roger Owen J, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Jane Dobbs H, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss JM, Yarnold JR. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14(11):1086\u201394. https:\/\/doi.org\/10.1016\/S1470-2045(13)70386-3.","journal-title":"Lancet Oncol"},{"key":"2669_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13014-022-02043-0","volume":"17","author":"N Maliko","year":"2022","unstructured":"Maliko N, Stam MR, Boersma LJ, Vrancken Peeters M-JT, Wouters MW, KleinJan E, Mulder M, Essers M, Hurkmans CW, Bijker N. Transparency in quality of radiotherapy for breast cancer in the Netherlands: a national registration of radiotherapy-parameters. Radiat Oncol. 2022;17:73. https:\/\/doi.org\/10.1186\/s13014-022-02043-0.","journal-title":"Radiat Oncol"},{"issue":"31","key":"2669_CR10","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1200\/JCO.20.01363","volume":"38","author":"BV Offersen","year":"2020","unstructured":"Danish Breast Cancer Group Radiation Therapy Committee, Offersen BV, Alsner J, Nielsen HM, Jakobsen EH, Nielsen MH, Krause M, Stenbygaard L, Mjaaland I, Schreiber A, Kasti U-M, Overgaard J. Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial. J Clin Oncol. 2020;38(31):3615\u201325. https:\/\/doi.org\/10.1200\/JCO.20.01363.","journal-title":"J Clin Oncol"},{"key":"2669_CR11","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00010","volume":"9","author":"OT Oladeru","year":"2023","unstructured":"Oladeru OT, Dunn SA, Li J, Coles CE, Yamauchi C, Chang JS, Cheng SH-C, Kaidar-Person O, Meattini I, Ramiah D. Looking Back: international practice patterns in breast radiation oncology from a case-based survey across 54 countries during the first surge of the COVID-19 pandemic. JCO Glob Oncol. 2023;9: e2300010. https:\/\/doi.org\/10.1200\/GO.23.00010.","journal-title":"JCO Glob Oncol"},{"key":"2669_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/apjon.apjon_46_17","volume":"5","author":"K Rastogi","year":"2018","unstructured":"Rastogi K, Jain S, Bhatnagar AR, Bhaskar S, Gupta S, Sharma N. A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients. Asia Pac J of Oncol Nurs. 2018;5:107\u201313. https:\/\/doi.org\/10.4103\/apjon.apjon_46_17.","journal-title":"Asia Pac J of Oncol Nurs"},{"key":"2669_CR13","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"2004","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. John Wiley & Sons; 2004."},{"key":"2669_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1470-2045(20)30743-9","volume":"22","author":"K Spencer","year":"2021","unstructured":"Spencer K, Jones CM, Girdler R, Roe C, Sharpe M, Lawton S, Miller L, Lewis P, Evans M, Sebag-Montefiore D. The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study. Lancet Oncol. 2021;22:309\u201320. https:\/\/doi.org\/10.1016\/S1470-2045(20)30743-9.","journal-title":"Lancet Oncol"},{"key":"2669_CR15","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","volume":"371","author":"SM Bentzen","year":"2008","unstructured":"START Trialists\u2019 Group, Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, Bentzen SM, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DAL, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR. The UK standardisation of breast radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098\u2013107. https:\/\/doi.org\/10.1016\/S0140-6736(08)60348-7.","journal-title":"Lancet"},{"key":"2669_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","volume":"9","author":"SM Bentzen","year":"2008","unstructured":"START Trialists\u2019 Group, Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Bliss PJB-LJM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee J, Mills J, Morgan DAL, Owen JR, Simmons S, Sum G, Sydenham MA, Venables K, Yarnold JR. The UK standardisation of breast radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9:331\u201341. https:\/\/doi.org\/10.1016\/S1470-2045(08)70077-9.","journal-title":"Lancet Oncol"},{"key":"2669_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/jamaoncol.2016.3031","volume":"3","author":"C Vrieling","year":"2017","unstructured":"Vrieling C, van Werkhoven E, Maingon P, Poortmans P, Weltens C, Fourquet A, Schinagl D, Oei B, Rodenhuis CC, Horiot J-C. Prognostic factors for local control in breast cancer after long-term follow-up in the EORTC boost vs no boost trial: a randomized clinical trial. JAMA Oncol. 2017;3:42\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2016.3031.","journal-title":"JAMA Oncol"},{"key":"2669_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/jnci\/94.15.1143","volume":"94","author":"T Whelan","year":"2002","unstructured":"Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L, Lada B, Lukka H, Perera F, Fyles A, Laukkanen E, Gulavita S, Benk V, Szechtman B. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94:1143\u201350. https:\/\/doi.org\/10.1093\/jnci\/94.15.1143.","journal-title":"J Natl Cancer Inst"},{"key":"2669_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ, Pignol J-P, Levine MN, Julian JA, MacKenzie R, Parpia S, Shelley W, Grimard L, Bowen J, Lukka H, Perera F, Fyles A, Schneider K, Gulavita S, Freeman C. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513\u201320. https:\/\/doi.org\/10.1056\/NEJMoa0906260.","journal-title":"N Engl J Med"},{"issue":"3","key":"2669_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-015-3490-4","volume":"152","author":"A Witteveen","year":"2015","unstructured":"Witteveen A, Vliegen IM, Sonke GS, Klaase JM, IJzerman MJ, Siesling S. Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients. Breast Cancer Res Treat. 2015;152(3):627\u201336. https:\/\/doi.org\/10.1007\/s10549-015-3490-4.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02669-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02669-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02669-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T13:34:39Z","timestamp":1749735279000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-025-02669-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2669"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02669-w","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Privacy Review Board of the NCR confirmed that no ethical approval was required for the current study, because of the retrospective design and the anonymized patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"99"}}